MDBH PRESS-RELEASE SEC Filing Analysis

Final — all horizons settled through T+60d

MDBH ▲ +13.82% at T+60d

NEUTRAL call ✓ call won +13.82% · α vs SPY +2.30% · entry $2.88 → $3.28

Last close $2.86 (close Jun 12) · -0.69% from $2.88 entry

Entry anchored
Mar 11, 2026
via day open

T+1d

-2.08%

call -2.08% · α -0.60%

$2.82

settled 3mo ago

T+5d

-1.39%

call -1.39% · α +0.80%

$2.84

settled 3mo ago

T+20d

+19.79%

call +19.79% · α +19.27%

$3.45

settled 2mo ago

T+60d

+13.82%

call +13.82% · α +2.30%

$3.28

settled 10d ago

Price Chart

Loading chart...

Executive Summary

PatentVest, a division of MDBH, completed a strategic IP engagement with biotech firm Porosome Therapeutics, providing a comprehensive audit and competitive assessment of its intellectual property portfolio. The analysis validated Porosome's unique position in the emerging field of secretion restoration technologies, supporting its pursuit of partnerships and further IP expansion.

Actionable Insight

Monitor for future announcements of partnership activity or licensing deals by Porosome Therapeutics, which could indirectly benefit PatentVest through follow-on work or success-based fees. No immediate financial impact expected for MDBH.

Key Facts

PatentVest completed an IP portfolio audit, global patent landscape analysis, and competitive benchmarking for Porosome Therapeutics.
Porosome Therapeutics is developing Porosome Reconstitution Platforms (PRPs) to restore cellular secretion mechanisms, a novel approach distinct from traditional modulation therapies.
The engagement confirmed Porosome’s defensible IP position with minimal competitive overlap in structural porosome reconstitution.
Porosome is expanding its IP portfolio with new filings covering organoid models, peptides, and small molecules.
PatentVest is a division of MDBH and provides integrated IP intelligence and strategy services.

Financial Impact

No financial terms disclosed; likely a routine professional services engagement

revenueeps

Risk Factors

Revenue impact from this engagement is likely immaterial given lack of disclosed deal value.
PatentVest’s business model may depend on high-value outcomes for clients that do not always translate into direct financial upside for MDBH.

Market Snapshot

Exchange

Nasdaq

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

Document	Accession Number
PRESS-RELEASE Data (Synthetic)	press-3254029

2 reports for MDBH

T+1T+5T+20T+60

Filters

Reports for MDBH — sortable, filterable
	Type				Now
Mar 23, 2026 11w ago	Press Release NEUTRAL ★ 3/10	$2.88 $3.85	▲ +33.68%	▲ +26.26%	$2.86 (−0.69%)
Mar 11, 2026 13w ago	Press Release NEUTRAL ★ 4/10	$2.88 $3.45	▲ +19.79%	▲ +19.27%	$2.86 (−0.69%)

US Market Status

Market Closed — Opens in 4h 33m

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access